HBIO icon

Harvard Bioscience
HBIO

Overview Fund Activity

93 hedge funds and large institutions have $177M invested in Harvard Bioscience in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 8 closing their positions.

Holders
93
Holders Change
-1
Holders Change %
-1.06%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
32
Reduced
29
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PCM
1
Portolan Capital Management
Massachusetts
$3.6M
2
BlackRock
2
BlackRock
New York
$15.6M
3
Morgan Stanley
3
Morgan Stanley
New York
$1.17M
4
GIM
4
Granahan Investment Management
Massachusetts
$9.86M
5
BFM
5
Boothbay Fund Management
New York
$7.29M

Top Sellers

1
2C
1
272 Capital
Texas
$15.7M
2
Millennium Management
2
Millennium Management
New York
$336K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$563K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$285K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$5.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
101
Citadel Advisors
Florida
– -$8.13K -1,890 Closed
1 2 3 4
5